Vascular Effects of Statins in Stroke
Stroke 28:2315-2320, Delanty,N.&Vaughan,C.J., 1997
Influence of Cholesterol on Survival After Stroke:Retrospective Study
BMJ 314:1584-1588, Dyker,A.G.,et al, 1997
Reduction in Carotid Arterial Wall Thickness Using Lovastatin & Dietary Therapy
Ann Int Med 124:548-556, Hodis,H.N.,et al, 1996
Pravastatin Reduces Carotid Intima-Media Thickness Prog in an Asympt Hypercholesterolemic Pop, CAIUS Study
Am J Med 101:627-634, Mercuri,M.,et al, 1996
Parkinsonism Unmasked by Lovastatin
Ann Neurol 37:685-686, Muller,T.,et al, 1995
Peripheral Neuropathy with Bezafibrate
BMJ 309:929, Ellis,C.J.,et al, 1994
HMG-CoA Reductase Inhibitor Therapy and Peripheral Neuropathy
Ann Int Med 120:970, Jacobs,M.B., 1994
One-Year Reduction and Longitudinal Analysis of Carotid Intima-Media Thickness Associated with Colestipol/Niacin Therapy
Stroke 24:1779-1783, Mack,W.J.,et al, 1993
Gemfibrozil-Induced Myopathy
Arch Int Med 151:1873-1874, Magarian,G.J.,et al, 1991
Cholesterol-Lowering Agent Myopathy (CLAM)
Neurol 41:1159-1160, London,S.F.,et al, 1991
Myopathy and Rhabdomyolysis Associated with Lovastatin-Gemfibrozil Combination Therapy
JAMA 264:71-75, Pierce,L.R.,et al, 1990
Atherosclerosis:Current Concepts on Pathogenesis and Interventional Therapies
Ann Neurol 26:3-12, Yatsu,F.M.&Fisher,M., 1989
Drug-Induced Myopathies In Man
Lancet 2:562-566, Lane,R.J.M.,et al, 1978
Clofibrate-Induced Muscle Damage with Myoglobinuria & Cardiomyopathy
NEJM 296:942, Smals,A.G.H., 1977
Platelet-Inhibiting Drugs in the Prevention of Clinical Thrombotic Disease
NEJM 293:174, Genton,E.,et al, 1975
The Treatment of Cerebrovascular Disease with Clofibrate
VA Cooperative Study Group, Stroke 4:6841973., , 1973
Muscular Syndrome after Clofibrate
NEJM 286:1110, Katsilambros,N., 1972
Clofibrate for the Treatment of Occlusive CVD-Correspondence
NEJM 287:671, Hirsch,S.,et al, 1972
Intravenous Thrombolysis for Acute Ischemic Stoke - New Dimensions
NEJM 395:1841-1847, Grotta,J.C., 2026
2026 Guideline for the Early Management of Patients with Acute Ischemic Stroke:A Guideline from the American Heart Association/American Stroke Association
Stroke 57:e316-e436, Prabhakaran,S.,et al, 2026
Zorevunersen in Children and Adolescents with Dravet Syndrome
NEJM 394:969-982, Laux,L.,et al, 2026
Progressive Quadriparesis and Falls in a 66-Year-Old Man With Longstanding Human Immunodeficiency Virus
Neurol 106:e214621, Ong,B.A. & Carlson,A.K., 2026
Intravenous Thrombolysis Use in the Late Time Window Before Interhospital Transfer for Thrombectomy
JAMA Neurol 83:60-67, Seners,P.,et al, 2026
Tenecteplase for Acute Non-Large Vessel Occlusion 4.5 to 24 Hours After IschemicStroke, The OPTION Randomized Clinical Trial
JAMA doi:10.1001/JAMA.2026.0210, Ma,G.,et al, 2026
A Randomized Trial of Tenecteplase in Acute Central Retinal Artery Occlusion
NEJM 394:442-450, Ryan,S.J.,et al, 2026
Mucormycosis
NEJM 394:684-698, Kontoyiannia,D.P. & Walsh, T.J., 2026
Secondary Prevention after Ischemic Stroke
NEJM 394:784-792, Frie,K.L.,et al, 2026
A 41-Year-Old Man with Steroid-Responsive Hemiparesis
Neurol 106:e214088, Obaidi,Z.A.,et al, 2026
A 67-Year-Old Man with Exercise Intolerance nd Progressive Weakness
Neurol 106:e214830, Gosset,A.,et al, 2026
Bilateral Posterior Limb Internal Capsule T2 Hyperintensity and Severe Cerebellar Atrophy in 2 Lifelong Friends
Neurol 106:e218014, Inoue,H.,et al, 2026
Status Epilepticus After Carotid Endarterectomy:An Illustrative Case of Cerebral Hyperfusion Syndrome
Stroke 57:e188-191, Reuter,P.,et al, 2026
Endovascular Therapy for Medium-Vessel Occlusion Stroke - Narrowing the Target Population
NEJM 394:1955-1957,1894, Ospel,J.M. & Hill, M.D., 2026
A 35-Year-Old Patient with Rapidly Progressive Ascending Weakness Leading to Loss of Brainstem Reflexes
Neurol 106:e218059, Lyons,H.J.,et al, 2026
Safety and Outcomes of Dibigatran Reversal with Idarucizumab Before IV Thrombolysis in Patients with Acute Ischemic Stroke
Neurol 106:e218012, Saflund,M.,et al, 2026
A New Era in Neurology
Lancet 407:2141, Editorial, 2026
Alzheimers Disease
Lancet 407:2241-2262, Serrano-Pozo, A.,et al, 2026
IV Thrombolysis Before Thrombectomy in Carotid Artery Dissection-Related Large-Vessel Occlusion
Neurol 106:e 218125, Hotz,J.F.,et al, 2026
Diffuse Cerebellar Involvement with Obstructive Hydrocephalus in Powassan Virus Encephalitis
Neurol 107:e218290, Xu,Z.,et al, 2026
Chronic Hepatitis E-Associated Myelitis in an Immunocompromised Patient
Neurol 107:e218253, Huby,S.,et al, 2026
Measles Inclusion-Body Encephalitis after Allogeneic Stem-Cell Transplantation
NEJM 395:203-205, Nemoz,B.,et al, 2026
Efficacy and Safety of Ecopipam for Tourette Syndrome A Phase 3 Randomized Clinical Trial
JAMA Neurol 83:645-653, Gilbert,D.L.,et al, 2026
Clinicopathologic Conference, Neuroretinitis Due to Bartonella Henselae Infection
NEJM 395:389-398, Case 21-2026, 2026
A 79-Year-Old Man with Subacute Facial Movements and Discoordination
Neurol 107:e21838, Plaza-Jennings,et al, 2026
Cytomegalovirus Infection and Cryptococcal Infection in Patient with Immunosuppression with Myasthenia Gravis
NEJM 395:804-815, Ankomah,P.O.,et al, 2026
Glucagon-Like Peptide-1 Receptor Agonists and Wernicke Encephalopathy:A Pharmacovigilance Study and Literature Review
Clin Nutr 57:106571, Lev,D.,et al, 2026
Efficacy and Safety of Gefurulimab in Generalized Myasthenia Gravis, The PREVAIL Phase 3 Randomized Clinical Trial
JAMA Neurol 83:841-850, Gwathmey,K.G.,et al, 2026
Clinicopathologic Conference, Wernicke-Korsakoff Syndrome
NEJM 395:1113-1121, Case 26-2026, 2026
Outcomes of Intra-Arterial Tenecteplase after Endovascular Reperfusion for Acute Ischemic Stroke Due to Cardioembolism and Non-Cardioembolism: A Secondary Analysis of the POST-TNK Trial
Ann Neurol 100:841-849, Chai,M.,et al, 2026
Radiation-Induced Carotid Artery Stenosis in Patients with Head and Neck Cancer: A Comprehensive Review of Imaging Features, Pathogenesis, and Clinical Manifestations
AJNR 47:2478-2485, Wiepert,L.M.,et al, 2026
Brexpiprazole-Induced Tardive Dystonia
Neurol 107:e218603, Anekwe,J.,et al, 2026